The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
RKB...well done sir !!
so in effect, if you own under 3% you are a nobody !!!
nice to know what they think of shareholders ..........the word transparency means nothing here................
Well done RKB. Their website is a really cheap effort and could do with a revamp. Especially if they want to attract a bit more interest
Good Morning Buysellfredmfc
I have a had a detailed, informative and polit response from our Investor Relations Adviser, Tim Metcalfe.
We have an updated list of Major Shareholders on our website, but it is not accurate.
Monecor (London) Ltd reduced their holdings by 16.5 million and we had this TR1 issued on the 7th of June 2021 and it was within the FCA Rules as they reduced on Friday the 4th June 2021 and technically the RNS was issued the next day (business day) Unlike Spreadex who were 10 days late and Cantor Fitzgerald Europe who were about 47 days late.
The Major Shareholders were updated on the 14th of June 2021 “the Company is aware of the following significant nominee holdings (over 3%) of voting rights in its share capital. The Company is not aware of any Shareholders other than the Directors that, directly or indirectly, hold beneficial interests in three percent or more of the Ordinary Shares or voting rights.”
If the “Company is aware of” then why was the reduction of Monecor (London) not included in the major shareholders update?
Path Investments Plc have 4 Directors (on reduced remuneration so they say!) and the only means for an investor or potential investor to make an informed decision is to rely on the information on the company website.
I think the Company are maybe getting the message that I expect changes and soon.
RKB
Still no reply ?!!!
Margaux 82.... nice $1000 plonk !!
Spreadex Ltd & FCA
I have this morning communicated again with the FCA about the late notification of a TR1 shareholding.
Spreadex Ltd were also late when they advised Path Investments Plc on the 8th of April 2021 when they crossed a threshold on the 25th of March 2021.
There is a pattern of late disclosure of a change in a major shareholding with Path and small shareholders could be at a disadvantage from a lack of information that the FCA stipulates in their hand-book.
How many more major shareholders will TR1 over the next few weeks?
RKB